Conditionally-Immortalised iPSCs: A New Approach to Off-the-Shelf Allogeneic iPSC-Derived Cell Therapies

Time: 4:00 pm
day: Day Two


  • Reprogramming conditionally immortalised adult stem cells to pluripotency generates true iPSCs with some unique properties
  • Use of the conditional immortalisation technology to produce clinically-relevant cells such as tissue progenitors: proof-of-principle for a system to manufacture (iPSC-derived) specific cell types at scale
  • Towards GMP conditionally-immortalised iPSCs: clinical-grade, bankable, adult stem cells and other therapeutic cells for allogeneic, off-the-shelf cell therapy